This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (40)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

IRVING M. ARIEL, MD; GEORGE T. PACK, MD

AMA Arch Surg. 1965;91(5):851-862.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

PATIENTS suffering from inoperable cancer of the liver usually die within an average of six months after diagnosis.¹ This is particularly true of cancer metastatic to the liver, regardless of the type of therapy. Some beneficial results have been obtained by the surgical excision of the metastases in the liver. However, the overall results leave much to be desired, and 21 of 28 patients so treated have ultimately died from their cancers.²

The liver tolerates large doses of external irradiation, and such therapy sometimes can be beneficial in those patients with localized metastases. Unfortunately, metastases to the liver generally constitute a focus for the intrahepatic dissemination of additional metastases within the liver; consequently the liver is often studded with numerous metastatic deposits, making it impossible to deliver a cancerocidal dose of irradiation to the entire organ.

Metastases usually reach the liver via the portal system; less frequently via . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Pack Medical Foundation and the Department of Surgery, New York Medical College-Flower and Fifth Avenue Hospitals.

Footnotes
Submitted for publication April 4, 1965.

Reprint requests to 139 E 36th St, New York, NY 10016 (Dr. Ariel).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?